SCHEMBL6592137

SCHEMBL6592137

Cc1cccc(C(=O)Nc2ccc(Cl)cc2)c1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALDH1A1 P00352 2/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
F10 P00742 3/20 0.51
PLAU P00749 2/20 0.50
PNLIP P16233 2/20 0.50
F2 P00734 1/20 0.50
PLG P00747 1/20 0.50
PLAT P00750 1/20 0.50
KLK1 P06870 1/20 0.50
KLK5 Q9Y337 1/20 0.50
AURKB Q96GD4 1/20 0.50
NPSR1 Q6W5P4 3/20 0.49
PKM P14618 1/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
ALOX15 P16050 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22720100 0.86 HPGD (0.72) HPGDSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL2119568 0.84 HPGD (0.74) HPGDSMN1; SMN2ALDH1A1HDAC1HDAC8
SCHEMBL2700622 0.83 SMN1; SMN2 (0.67) HPGDSMN1; SMN2ALDH1A1HDAC1HDAC8
SCHEMBL5225897 0.82 NPC1 (0.74) SMN1; SMN2ALDH1A1PNLIPNPC1RAB9A
SCHEMBL5533204 0.82 NPC1 (0.50) SMN1; SMN2ALDH1A1HDAC8PNLIPAURKB
SCHEMBL6107835 0.82 RAB9A (0.76) SMN1; SMN2ALDH1A1F10PKMNPC1
SCHEMBL6589682 0.82 BCL2L1 (0.60) ALDH1A1HDAC1HDAC8HDAC6F10
SCHEMBL6593998 0.81 JAK2 (0.58) SMN1; SMN2ALDH1A1HDAC8F10PNLIP
SCHEMBL11750551 0.80 KDR (0.54) HPGDSMN1; SMN2ALDH1A1F10PLAU
SCHEMBL11745378 0.79 POLB (0.65) HPGDSMN1; SMN2ALDH1A1PKMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1143855-C I (ortho)-anthranilamide derivatives as anti-coagulants ���ֹɷݹ�˾ 2004-03-31 CN disclosed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
CN-1282329-A I (ortho)-anthranilamide derivatives as anti-coagulants SCHERING AG (DE) 2001-01-31 CN disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed